S. Quenby, Katie Booth, Louise Hiller, A. Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, L. Scheres, T. V. van Haaps, L. Ewington, Shreeya Tewary, M. Goddijn, Saskia Middeldorp
{"title":"肝素治疗复发性流产和遗传性血栓性妇女（ALIFE2）：一项国际开放标签随机对照试验","authors":"S. Quenby, Katie Booth, Louise Hiller, A. Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, L. Scheres, T. V. van Haaps, L. Ewington, Shreeya Tewary, M. Goddijn, Saskia Middeldorp","doi":"10.1097/01.ogx.0001006880.59476.45","DOIUrl":null,"url":null,"abstract":"(Abstracted from Lancet 2023;402:54–61)\n Inherited thrombophilia is implicated as a cause of recurrent pregnancy loss, defined as the loss of 2 or more pregnancies. Heparin is the standard treatment for acquired thrombophilia but is not recommended in cases of recurrent pregnancy loss and inherited thrombophilia.","PeriodicalId":509854,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"15 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial\",\"authors\":\"S. Quenby, Katie Booth, Louise Hiller, A. Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, L. Scheres, T. V. van Haaps, L. Ewington, Shreeya Tewary, M. Goddijn, Saskia Middeldorp\",\"doi\":\"10.1097/01.ogx.0001006880.59476.45\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"(Abstracted from Lancet 2023;402:54–61)\\n Inherited thrombophilia is implicated as a cause of recurrent pregnancy loss, defined as the loss of 2 or more pregnancies. Heparin is the standard treatment for acquired thrombophilia but is not recommended in cases of recurrent pregnancy loss and inherited thrombophilia.\",\"PeriodicalId\":509854,\"journal\":{\"name\":\"Obstetrical & Gynecological Survey\",\"volume\":\"15 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obstetrical & Gynecological Survey\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.ogx.0001006880.59476.45\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrical & Gynecological Survey","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.ogx.0001006880.59476.45","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial
(Abstracted from Lancet 2023;402:54–61)
Inherited thrombophilia is implicated as a cause of recurrent pregnancy loss, defined as the loss of 2 or more pregnancies. Heparin is the standard treatment for acquired thrombophilia but is not recommended in cases of recurrent pregnancy loss and inherited thrombophilia.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
